| Filed On | Filing |
|---|---|
| 12 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
This NOTE AMENDMENT AND CONVERSION AGREEMENT (this “Agreement”) is dated as of November 10, 2026, by and among NexGel, Inc., a Delaware corporation (the “Company”), and the noteholder identified on the signature page hereto (the “Holder”). |
| 07 Oct 2026 |
8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
NexGel, Inc. (the “Corporation”), a corporation duly organized and existing under the laws of the State of Delaware, by its duly authorized officer, does hereby certify that: |
| 24 Sep 2026 |
8-K: Regulation FD Disclosure
On September 24, 2026, NexGel, Inc. began utilizing a new shareholder update presentation entitled “Strategic Review & Proposed Platform Reorganization,” a copy of which is attached hereto as Exhibit 99.1. |
| 23 Sep 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On September 23, 2026, NexGel, Inc. (the “Company”) held its 2026 Special Meeting of Stockholders (the “Special Meeting”). At the Special Meeting, there were 6,200,043 shares of common stock represented in person or by proxy of the 9,747... |
| 21 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
LANGHORNE, Pa. – August 20, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”) today announced a series of leadership, governance and strategic initiatives designed to strengthen operational execution, improve liquidity, an... |
| 17 Aug 2026 |
8-K: Results of Operations and Financial Condition
LANGHORNE, Pa. – August 17, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for ... |
| 05 Aug 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On July 31, 2026, NexGel, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, there were 6,398,925 shares of common stock represented in person or by proxy of the 9,225,242 sha... |
| 29 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
This Executive Employment Agreement (this “Agreement”), effective as of July 23, 2026 (the “Effective Date”), is by and between NEXGEL, INC., a Delaware corporation (the “Company”), and Adam Levy, an individual (“Executive”). The Company... |
| 09 Jul 2026 |
8-K: Other Events
On July 9, 2026, NexGel, Inc. (the “Company”) elected to postpone of the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”), which was previously scheduled to be held on July 10, 2026, to July 31, 2026 at 10:00 a.m., Ea... |
| 02 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 17 Jun 2026 |
8-K: Regulation FD Disclosure
On June 17, 2026, NexGel, Inc. began utilizing a new investor presentation, a copy of which is attached hereto as Exhibit 99.1. |
| 15 May 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May [__], 2026, by and between NEXGEL, INC., a Delaware corporation, with headquarters located at 2150 Cabot Blvd West, Suite B, Langhorne, PA 19047 (the “Company”), and t... |
| 12 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Other Events
Sequence LifeScienceTM Led Financing to Close on Acquisition of Celularity with Strategic Investment of $5.5 Million |
| 30 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Other Events
This Executive Employment Agreement (this “Agreement”), effective as of April 27, 2026 (the “Effective Date”), is by and between NexGel, a Delaware corporation (the “Company”), and Ian Blackman, an individual (“Executive”). The Company a... |
| 24 Apr 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
On April 22, 2026, NexGel, Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutiv... |
| 21 Apr 2026 |
8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +3 more
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April [__], 2026, by and between NEXGEL, INC., a Delaware corporation, with headquarters located at 2150 Cabot Blvd West, Suite B, Langhorne, PA 19047 (the “Company”), and... |
| 10 Mar 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. |
| 11 Feb 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 9, 2026, is by and among NexGel, Inc., a Delaware corporation with offices located at 2150 Cabot Blvd West, Suite B, Langhorne, Pennsylvania 19047 (the “Company”)... |
| 30 Jan 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Effective as of February 2, 2026, I hereby resign as a member of the Board of Directors (the “Board”) of NexGel, Inc. (the “Company”), including as a member of any and all committees of the Board of Director on which I serve. |
| 07 Jan 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Loading...